Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Detailed Status

Completed3

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting120%

completed360%

recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

active_not_recruiting

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

NCT05096754

completednot_applicable

Trial of the TransMedics Organ Care System™ Liver For Preserving and Assessing Donor Livers for Transplantation

NCT02449694

Clinical Trials (5)

Showing 5 of 5 trials

NCT05074160

OCS Liver Perfusion (OLP) Post-Approval Registry

Active Not Recruiting

NCT05940857

US National OCS Liver Perfusion (OLP) Registry

Recruiting

NCT05096741

OCS Liver PROTECT Continuation Post-Approval Study

Completed

NCT05096754

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

Completed

NCT02449694Not Applicable

Trial of the TransMedics Organ Care System™ Liver For Preserving and Assessing Donor Livers for Transplantation

Completed

All 5 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 5